Cassava Sciences, Inc. (SAVA)

Cassava Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-97.22	-76.25	-32.39	-6.33	-4.63
Depreciation & Amortization	1.53	1.3	0.53	0.02	0.06
Share-Based Compensation	4.59	2.07	1.76	0.99	1.3
Other Operating Activities	9.08	-4.64	-0.1	-0.06	0.76
Operating Cash Flow	-82.03	-77.51	-30.2	-5.38	-2.51
Capital Expenditures	-0.41	-2.71	-22.21	0.36	-0.02
Investing Cash Flow	-0.41	-2.71	-22.21	0.36	-0.02
Share Issuance / Repurchase	2.56	47.8	192.34	75.45	5.87
Other Financing Activities	-	-	-	-	-0.06
Financing Cash Flow	2.56	47.8	192.34	75.45	5.81
Net Cash Flow	-79.88	-32.42	139.93	70.43	3.27
Free Cash Flow	-82.44	-80.23	-52.41	-5.02	-2.53
Free Cash Flow Per Share	-1.97	-2.00	-1.33	-0.19	-0.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).